EU/US Properties Organoleptics Cosmetics Suppliers Safety Safety in use Safety references References Other Blenders Uses Occurrence Synonyms Articles Notes
 

magnesium pidolate
magnesium, bis(5-oxo-L-prolinato-N1,O2)-, (T-4)-

Supplier Sponsors

Name:magnesium 5-oxopyrrolidine-2-carboxylic acid
CAS Number: 62003-27-4Picture of molecule3D/inchi
ECHA EINECS - REACH Pre-Reg:263-365-7
FDA UNII: V5PC588N7G
MDL:MFCD00792303
Molecular Weight:153.42039000
Formula:C5 H7 Mg N O3 +2
NMR Predictor:Predict (works with chrome, Edge or firefox)
Category:nutrient supplements
 
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Google Scholar:Search
Google Books:Search
Google Scholar: with word "volatile"Search
Google Scholar: with word "flavor"Search
Google Scholar: with word "odor"Search
Perfumer and Flavorist:Search
Google Patents:Search
US Patents:Search
EU Patents:Search
Pubchem Patents:Search
PubMed:Search
NCBI:Search
 
Physical Properties:
Assay: 95.00 to 100.00
Food Chemicals Codex Listed: No
Boiling Point: 453.10 °C. @ 760.00 mm Hg (est)
Vapor Pressure:0.000000 mmHg @ 25.00 °C. (est)
Flash Point: 442.00 °F. TCC ( 227.80 °C. ) (est)
logP (o/w): -2.387 (est)
 
Organoleptic Properties:
Odor and/or flavor descriptions from others (if found).
 
Cosmetic Information:
None found
 
Suppliers:
American International Chemical, LLC.
Magnesium Pidolate
Global Calcium
Magnesium Pidolate EP/BP
Pangaea Sciences
Magnesium pidolate
Sigma-Aldrich: Sigma
For experimental / research use only.
Magnesium L-pidolate 98.0-102.0% (calc. on dry substance, T)
sds
Solabia
Magnesium Pidolate
Odor: characteristic
Use: Magnesium Pidolate is a very soluble form of magnesium. Even in high concentrations it provides perfectly clear solutions ideal for medicinal forms in liquid single doses and powders for drinkable solutions.
 
Safety Information:
Preferred SDS: View
 
Hazards identification
 
Classification of the substance or mixture
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)
None found.
GHS Label elements, including precautionary statements
 
Pictogram
 
Hazard statement(s)
None found.
Precautionary statement(s)
None found.
Oral/Parenteral Toxicity:
Not determined
Dermal Toxicity:
Not determined
Inhalation Toxicity:
Not determined
 
Safety in Use Information:
Category:
nutrient supplements
Recommendation for magnesium pidolate usage levels up to:
 not for fragrance use.
 
Recommendation for magnesium pidolate flavor usage levels up to:
 not for flavor use.
 
Safety References:
European Food Safety Authority (EFSA) reference(s):

Opinion of the Scientific Panel on food additives, flavourings, processing aids and materials in contact with food (AFC) related to Calcium, iron, magnesium, potassium and zinc L-pidolate as sources for calcium, iron, magnesium, potassium and zinc added for nutritional purposes to food supplements and to foods intended for particular nutritional uses
View page or View pdf

AIDS Citations:Search
Cancer Citations:Search
Toxicology Citations:Search
EPA ACToR:Toxicology Data
EPA Substance Registry Services (SRS):Registry
Laboratory Chemical Safety Summary :3085235
National Institute of Allergy and Infectious Diseases:Data
WGK Germany:3
magnesium 5-oxopyrrolidine-2-carboxylic acid
Chemidplus:0062003274
 
References:
 magnesium 5-oxopyrrolidine-2-carboxylic acid
NIST Chemistry WebBook:Search Inchi
Pubchem (cid):3085235
Pubchem (sid):135233768
 
Other Information:
(IUPAC):Atomic Weights of the Elements 2011 (pdf)
Videos:The Periodic Table of Videos
tgsc:Atomic Weights use for this web site
(IUPAC):Periodic Table of the Elements
HMDB (The Human Metabolome Database):Search
FDA Listing of Food Additive Status:View
ChemSpider:View
Wikipedia:View
 
Potential Blenders and core components note
None Found
 
Potential Uses:
None Found
 
Occurrence (nature, food, other):note
 not found in nature
 
Synonyms:
 MAG2
 magnesium 5-oxopyrrolidine-2-carboxylic acid
 magnesium, bis(5-oxo-L-prolinato-N1,O2)-, (T-4)-
bis(5-oxo-L-prolinato-N1,O2)magnesium
bis(5-oxo-laevo-prolinato-N1,O2)magnesium
 

Articles:

PubMed:Late Outcome of a Randomized Study on Oral Magnesium for Premature Complexes.
PubMed:Effects of magnesium supplements on blood pressure, endothelial function and metabolic parameters in healthy young men with a family history of metabolic syndrome.
PubMed:Effects of supplementation with different Mg salts in cells: is there a clue?
PubMed:Promising therapies in sickle cell disease.
PubMed:Phase I study of magnesium pidolate in combination with hydroxycarbamide for children with sickle cell anaemia.
PubMed:Magnesium as a preventive treatment for paediatric episodic tension-type headache: results at 1-year follow-up.
PubMed:[Clinical trials of new therapeutic pharmacology for sickle cell disease].
PubMed:Magnesium as a treatment for paediatric tension-type headache: a clinical replication series.
PubMed:Intracellular Mg2+ diffusion within isolated rat skeletal muscle fibers.
PubMed:Oral magnesium pidolate: effects of long-term administration in patients with sickle cell disease.
PubMed:Magnesium pidolate and magnesium aspartate effects on human amniotic membrane ionic permeability in vitro.
PubMed:The effect of dietary magnesium supplementation on the cellular abnormalities of erythrocytes in patients with beta thalassemia intermedia.
PubMed:Visual evoked potentials and serum magnesium levels in juvenile migraine patients.
PubMed:Reversible model of magnesium depletion induced by systemic kainic acid injection in magnesium-deficient rats: I--Comparative study of various magnesium salts.
PubMed:Inhibition of mouse-killing behaviour in magnesium-deficient rats: effect of pharmacological doses of magnesium pidolate, magnesium aspartate, magnesium lactate, magnesium gluconate and magnesium chloride.
PubMed:Effects of oral magnesium supplementation on plasma lipid concentrations in patients with non-insulin-dependent diabetes mellitus.
PubMed:[Magnesium in the prophylaxis of primary headache and other periodic disorders in children].
PubMed:Intravenous and oral magnesium supplementations in the prophylaxis of cisplatin-induced hypomagnesemia. Results of a controlled trial.
PubMed:Long-term magnesium supplementation in essential hypertension.
PubMed:Effectiveness of magnesium pidolate in the prophylactic treatment of primary dysmenorrhea.
PubMed:[Effects of magnesium pidolate on cardiovascular hemodynamics].
PubMed:Magnesium pidolate in the treatment of seasonal allergic rhinitis. Preliminary data.
 
Notes:
None found
Please share your Comments.
Email Address:
Top of Page Home
Copyright © 1980-2021 The Good Scents Company (tgsc) ™ Disclaimer Privacy Policy